ZIG
Zuckerman Investment Group Portfolio holdings
AUM
$1.03B
1-Year Return
28.22%
This Quarter Return
+0.23%
1 Year Return
+28.22%
3 Year Return
+125.88%
5 Year Return
+219.98%
10 Year Return
+379.42%
AUM
$424M
AUM Growth
-$28.3M
(-6.3%)
Cap. Flow
-$44.8M
Cap. Flow
% of AUM
-10.58%
Top 10 Holdings %
Top 10 Hldgs %
42.61%
Holding
66
New
1
Increased
13
Reduced
26
Closed
–
Top Buys
| 1 |
CVET
Covetrus, Inc. Common Stock
CVET
|
$3.59M |
| 2 |
Treehouse Foods
THS
|
$3.13M |
| 3 |
QVCGA
QVC Group, Inc. Series A Common Stock
QVCGA
|
$2.88M |
| 4 |
Ralph Lauren
RL
|
$2.59M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$595K |
Top Sells
| 1 |
Scholastic
SCHL
|
$8.35M |
| 2 |
Motorola Solutions
MSI
|
$7.4M |
| 3 |
CSW
CSW Industrials, Inc.
CSW
|
$7.11M |
| 4 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
$4.05M |
| 5 |
Comcast
CMCSA
|
$3.8M |
Sector Composition
| 1 | Industrials | 27.79% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Financials | 14.03% |
| 4 | Healthcare | 12.07% |
| 5 | Communication Services | 12.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Diageo
DEO
$61B
| $347K | 0.08% |
2,125
| – | – |
|
|
ATRS
52
DELISTED
Antares Pharma, Inc.
ATRS
| $334K | 0.08% |
100,000
| – | – |
|
53
Becton Dickinson
BDX
$54.3B
| $333K | 0.08% |
1,348
| – | – |
|
54
Exxon Mobil
XOM
$479B
| $312K | 0.07% |
4,425
+84
| +2% | +$5.92K |
|
55
JPMorgan Chase
JPM
$831B
| $311K | 0.07% |
2,646
+75
| +3% | +$8.82K |
|
|
GAM
56
General American Investors Company
GAM
$1.4B
| $279K | 0.07% |
7,664
| – | – |
|
57
Calamos Strategic Total Return Fund
CSQ
$2.99B
| $271K | 0.06% |
21,297
| – | – |
|
58
Hancock Whitney
HWC
$5.3B
| $216K | 0.05% |
5,643
| – | – |
|
59
AT&T
T
$211B
| $208K | 0.05% |
+7,293
| New | +$208K |
|
|
CVA
60
DELISTED
Covanta Holding Corporation
CVA
| $176K | 0.04% |
10,200
| – | – |
|
|
AEF
61
abrdn Emerging Markets Equity Income Fund
AEF
$248M
| $92K | 0.02% |
13,163
| – | – |
|
62
GE Aerospace
GE
$297B
| $89K | 0.02% |
2,006
| – | – |
|
63
Teva Pharmaceuticals
TEVA
$21.3B
| $72K | 0.02% |
10,406
| – | – |
|
|
GCVRZ
64
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $23K | 0.01% |
41,748
| – | – |
|